BDRX
Biodexa Pharmaceuticals
$3.90
−$0.24 (−5.8%)Oct 29, 2026
Key metrics
The numbers that frame BDRX today
- Market cap
- $220.17K
- ROIC
- -215.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.70
- 52wk High
- $357.60
Growth
Revenue and earnings trend for BDRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BDRX
Is Biodexa Pharmaceuticals a good buy?
No. Biodexa Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup.
What is the market capitalization of BDRX?
Biodexa Pharmaceuticals's market capitalization is $220.17K.
What is the 52-week high for BDRX stock?
The 52-week high for Biodexa Pharmaceuticals is $357.60. The current close of $3.90 is 98.9% below that high.
What is the 52-week low for BDRX stock?
The 52-week low for Biodexa Pharmaceuticals is $2.70. The current close of $3.90 is 44.7% above that low.
Does BDRX stock pay dividends?
Biodexa Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BDRX?
Biodexa Pharmaceuticals's Debt / Equity ratio is 0.